A recent study in JAMA Internal Medicine revealed that acupuncture significantly reduced chronic sciatica pain compared to sham acupuncture, with lasting benefits of up to 52 weeks.
An experimental long-acting steroid has shown promising results in providing long-lasting pain relief for knee osteoarthritis, with minimal side effects. Eupraxia Pharmaceuticals plans to conduct a larger Phase III trial for this innovative treatment. (Source: The Lancet Rheumatology)
A recent study in JAMA Health Forum found that patients treated by altruistic physicians had lower healthcare spending and were less likely to experience preventable hospital admissions and emergency department visits.
New EULAR criteria classify hand osteoarthritis phenotypes using radiographic features, enabling more targeted clinical trials for specific joint involvement patterns.
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Over 22% of rheumatoid arthritis patients experienced persistent severe pain despite improvements in disease activity after 24 weeks of DMARD therapy, highlighting the complex relationship between inflammation and pain in RA.
A study of over 3.5 million adults found that individuals with age-related macular degeneration had an 11% higher risk of developing rheumatoid arthritis, suggesting a potential link between eye and joint health.
EULAR's latest recommendations for systemic sclerosis treatment include 22 evidence-based guidelines across 8 clinical domains, marking a significant expansion from the 16 recommendations in 2017.